2023 Form 5500 filing — Orchard Therapeutics 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240725095451NAL0022150256001) for Orchard Therapeutics 401(K) Plan, reported by Orchard Therapeutics North America under EIN 81-2354450 and plan number 001. It reports 134 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240725095451NAL0022150256001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Orchard Therapeutics North America
- EIN
- 81-2354450
- Plan number
- 001
- Location
- Foster City, CA
- Participants
- 134
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $9,555,839
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $9,555,839
- Employer contributions
- $356,610
- Participant contributions
- $692,561
- Total income / additions
- $2,647,482
- Benefits paid
- $1,610,304
- Administrative expenses
- $1,730
- Total expenses
- $1,612,034
- Net increase / (decrease)
- $1,035,448
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| T Rowe Price Rps Inc | NONE | $1,730 | $0 |
| Fidelity Funds | NONE | $0 | $0 |
| Dimensional Funds | NONE | $0 | $0 |
| Columbia Funds | NONE | $0 | $0 |
| Eaton Vance Funds | NONE | $0 | $0 |
| Prudential Funds | NONE | $0 | $0 |
| Mfs Funds | NONE | $0 | $0 |
| American Funds | NONE | $0 | $0 |
| Jp Morgan Funds | NONE | $0 | $0 |